Cargando…

Synthetic Lethality Reveals Mechanisms of Mycobacterium tuberculosis Resistance to β-Lactams

Most β-lactam antibiotics are ineffective against Mycobacterium tuberculosis due to the microbe’s innate resistance. The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains has prompted interest to repurpose this class of drugs. To identify the genetic determinants of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lun, Shichun, Miranda, David, Kubler, Andre, Guo, Haidan, Maiga, Mariama C., Winglee, Kathryn, Pelly, Shaaretha, Bishai, William R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Microbiology 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172077/ https://www.ncbi.nlm.nih.gov/pubmed/25227469 http://dx.doi.org/10.1128/mBio.01767-14

Ejemplares similares

Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis
por: Maiga, Mamoudou, et al.
Publicado: (2015)

Erratum to “Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis” [EBioMedicine 2 (8), August 2015, 868–873]
por: Maiga, Mamoudou, et al.
Publicado: (2015)

Aerosol Mycobacterium tuberculosis Infection Causes Rapid Loss of Diversity in Gut Microbiota
por: Winglee, Kathryn, et al.
Publicado: (2014)

Alterations in Phospholipid Catabolism in Mycobacterium Tuberculosis LysX Mutant
por: Maloney, Erin, et al.
Publicado: (2011)

Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis
por: Lee, Jong-Hee, et al.
Publicado: (2012)

Rv2190c, an NlpC/P60 Family Protein, Is Required for Full Virulence of Mycobacterium tuberculosis
por: Parthasarathy, Geetha, et al.
Publicado: (2012)

Successful Shortening of Tuberculosis Treatment Using Adjuvant Host-Directed Therapy with FDA-Approved Phosphodiesterase Inhibitors in the Mouse Model
por: Maiga, Mamoudou, et al.
Publicado: (2012)

Small Molecule-directed Immunotherapy against Recurrent Infection by Mycobacterium tuberculosis
por: Bhattacharya, Debapriya, et al.
Publicado: (2014)

Rapid in vivo detection of isoniazid-sensitive Mycobacterium tuberculosis by breath test
por: Choi, Seong Won, et al.
Publicado: (2014)

Indoleamides are active against drug-resistant Mycobacterium tuberculosis
por: Lun, Shichun, et al.
Publicado: (2013)

Synthetic lethality of Mycobacterium tuberculosis NADH dehydrogenases is due to impaired NADH oxidation
por: Xu, Yuanyuan, et al.
Publicado: (2023)

MDA5 RNA-sensing pathway activation by Mycobacterium tuberculosis promotes innate immune subversion and pathogen survival
por: Bullen, C. Korin, et al.
Publicado: (2023)

Design, Synthesis and Biological Evaluation of N-phenylindole Derivatives as Pks13 Inhibitors againstMycobacterium tuberculosis
por: Cai, Yanpeng, et al.
Publicado: (2022)

In Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Mycobacterium tuberculosis Clinical Isolates
por: Li, Fu, et al.
Publicado: (2018)

In vitro activity of new combinations of β-lactam and β-lactamase inhibitors against the Mycobacterium tuberculosis complex
por: Economou Lundeberg, Elin, et al.
Publicado: (2023)

Whole Genome Sequencing of Mycobacterium africanum Strains from Mali Provides Insights into the Mechanisms of Geographic Restriction
por: Winglee, Kathryn, et al.
Publicado: (2016)

In Vitro and In Vivo Studies of a Rapid and Selective Breath Test for Tuberculosis Based upon Mycobacterial CO Dehydrogenase
por: Maiga, Mamoudou, et al.
Publicado: (2014)

Optimizing β-Lactams against Tuberculosis
por: de Jager, Veronique R., et al.
Publicado: (2020)

Susceptibility of β-Lactam Antibiotics and Genetic Mutation of Drug-Resistant Mycobacterium tuberculosis Isolates in Korea
por: Park, Sanghee, et al.
Publicado: (2022)

803. Overcoming β-Lactam Resistance in Mycobacterium abscessus
por: Story-Roller, Elizabeth, et al.
Publicado: (2018)

Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis
por: Parveen, Sadiya, et al.
Publicado: (2023)

Identification of β-Lactams Active against Mycobacterium tuberculosis by a Consortium of Pharmaceutical Companies and Academic Institutions
por: Gold, Ben, et al.
Publicado: (2022)

Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis
por: Parveen, Sadiya, et al.
Publicado: (2023)

Gene Expression of Mycobacterium tuberculosis Putative Transcription Factors whiB1-7 in Redox Environments
por: Larsson, Christer, et al.
Publicado: (2012)

Synthetic Approaches toward Monocyclic 3‐Amino‐β‐lactams
por: Deketelaere, Sari, et al.
Publicado: (2017)

The Two-Domain LysX Protein of Mycobacterium tuberculosis Is Required for Production of Lysinylated Phosphatidylglycerol and Resistance to Cationic Antimicrobial Peptides
por: Maloney, Erin, et al.
Publicado: (2009)

Mycobacterium abscessus and β-Lactams: Emerging Insights and Potential Opportunities
por: Story-Roller, Elizabeth, et al.
Publicado: (2018)

A Fluorescence‐Based Assay for Screening β‐Lactams Targeting the Mycobacterium tuberculosis Transpeptidase Ldt(Mt2)
por: de Munnik, Mariska, et al.
Publicado: (2019)

Design, synthesis and evaluation of novel indole-2-carboxamides for growth inhibition of Mycobacterium tuberculosis and paediatric brain tumour cells
por: Alsayed, Shahinda S. R., et al.
Publicado: (2021)

The Impact of Mouse Passaging of Mycobacterium tuberculosis Strains prior to Virulence Testing in the Mouse and Guinea Pig Aerosol Models
por: Converse, Paul J., et al.
Publicado: (2010)

Bedaquiline Eliminates Bactericidal Activity of β-Lactams against Mycobacterium abscessus
por: Lindman, Marissa, et al.
Publicado: (2019)

Repurposing β-Lactams for the Treatment of Mycobacterium kansasii Infections: An In Vitro Study
por: Muñoz-Muñoz, Lara, et al.
Publicado: (2023)

Eradicating Pulmonary Mycobacterium abscessus: The Promise of Dual β-Lactam Therapy
por: Alahmdi, Bayan, et al.
Publicado: (2023)

Efficacy of β-lactam/β-lactamase inhibitor combination is linked to WhiB4-mediated changes in redox physiology of Mycobacterium tuberculosis
por: Mishra, Saurabh, et al.
Publicado: (2017)

Impact of pathobiological diversity of Mycobacterium tuberculosis on clinical features and lethal outcome of tuberculosis
por: Mokrousov, Igor, et al.
Publicado: (2022)

Allosteric cooperation in β-lactam binding to a non-classical transpeptidase
por: Ahmad, Nazia, et al.
Publicado: (2022)

Current tuberculosis diagnostic tools & role of urease breath test
por: Maiga, Mamoudou, et al.
Publicado: (2012)

Paradoxical Hypersusceptibility of Drug-resistant Mycobacteriumtuberculosis to β-lactam Antibiotics
por: Cohen, Keira A., et al.
Publicado: (2016)

Role of Mycobacterium tuberculosis pknD in the Pathogenesis of central nervous system tuberculosis
por: Be, Nicholas A, et al.
Publicado: (2012)

Essential Metabolites of Mycobacterium tuberculosis and Their Mimics
por: Lamichhane, Gyanu, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vmnnmpjqbjkrm4eq4fr1fg9k59